Paolino W, Resegotti L, Rossi M, Infelise V
Br Med J. 1973 Sep 15;3(5880):567-8. doi: 10.1136/bmj.3.5880.567.
A preliminary report is given of a trial of the T.R.A.P. regimen (thioguanine, rubidomycin, cytosine arabinoside, and prednisolone) for the treatment of acute myeloid leukaemia. Out of 27 patients treated 13 (48.1%) obtained complete remission. The treatment was well tolerated and produced especially good results in elderly patients.
关于采用T.R.A.P.方案(硫鸟嘌呤、柔红霉素、阿糖胞苷和泼尼松龙)治疗急性髓细胞白血病的试验给出了一份初步报告。在接受治疗的27例患者中,有13例(48.1%)获得完全缓解。该治疗耐受性良好,在老年患者中尤其取得了良好效果。